TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Feasibility
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: AUClast of captopril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of captopril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in systolic Blood Pressure from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in systolic Blood Pressure during a sit-up test or head-up tilt test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rate variability recorded by electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rate of intracranial hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of major adverse cardiac/cerebrovascular and peripheral vessel events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Pain Interference Measure
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Physical Function Measure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Infant Sensory Profile-2 (ISP-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prechtl's General Movements Assessments (GMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate (complete response [CR] + partial response [PR])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the timed up and go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal fluid levels of LTE4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Imaging Grade of Swallowing Toxicity (DIGEST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Theory of Mind
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of adverse events that are considered dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Participant Retention Feasibility
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participant Attendance Feasibility
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical response rate at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in local psoriasis severity index (LPSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental visit completeness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: State-anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ILI-related health outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ILI-related behavioral outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in the % of left ventricle (LV) with Coronary Flow Capacity (CFC)blue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in the % of left ventricle (LV) with Coronary Flow Capacity (CFC)green
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High density lipoprotein (HDL) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absence of toxicity/SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Severe haematological toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Muscle Tone and Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 5-Point Hedonic Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chemotherapy-induced Taste Alteration Scale (CITAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety and depression scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in Sympathetic Nerve Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in Cardiovascular markers - Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in Cardiovascular markers - Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline - Six Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline - Ten Meter Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse events after CEA-CAR-T cells infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of CEA-CAR-T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change in methylation of the FKBP5 gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upregulation of HLA l (HLA-ABC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Upregulation of HLA ll (HLA-DR/DQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse events related to IFN-γ
Endpoint domain: Adverse events/effects
Primary endpoint: Response to PAPR inhibitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial or respiratory viral infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Use of antibiotics or antivirals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Objective measure of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective measure of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs) related to apheresis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with clinically significant laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Pain scale (visual analogue scale, VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilometry variable x displacement open eyes before progressive pressure release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilometry variable center of pressure area open eyes after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with closed eyes after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of genitourinary syndrome of menopause
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Construct validity for acute pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical spinal fusion status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neck visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from severe ADEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Subjects with pacing capture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of serious game-assisted teaching intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total number of participants enrolled in the main clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total number of participants enrolled in the kidney biopsy substudy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ileus
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage Proportion of patients experiencing adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Social-behavioral readiness as assessed by the social-behavioral domain of the Kindergarten Readiness Assessment (KRA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of children who reported chronic absence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of children who retained in grade
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Migraine disability assessment (MIDAS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with post-operative mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Assessment of lipohypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain level-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dyspareunia severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of parabasal cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of superficial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical functioning measured using the PROMIS Physical Function Short Form 20
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical functioning measured using the Patient-Specific Functional Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical functioning measured using the Physical Performance Test (9-item)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Performance of daily living tasks using the Performance Assessment of Self-care Skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Executive functioning using the Dimensional Change Card Sort Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Executive functioning using the Executive Function Performance Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Antitumor immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 6-month Disease Control Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Primary outcome 3
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Primary outcome 4
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Kujala questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of moderate or severe COPD exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of cardiovascular complications/outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six-Minute Pegboard and Ring Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction accuracy of ES needs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Cervical muscles metabolism by the transverse relaxation time (T2) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head and neck movements during the cervical extensor endurance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving PASI 90 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of subjects achieving sPGA 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in meters walked during the Two minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain-Pressure Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of ROC curves for predicting fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of SARS-Cov-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of illness by COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of the efficacy of the first dose of the vaccine against COVID-19
Endpoint domain: Physiological/clinical
Primary endpoint: Duration of the efficacy of the second dose of the vaccine against COVID-19
Endpoint domain: Physiological/clinical
Primary endpoint: Changes of pain on a 0-100mm VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of quality of life index defined by EQ5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Obtention of an acceptable Symptom State assessed by the PASS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resolution of nonalcoholic steatohepatitis (NASH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in well-being from baseline (patient)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in well-being from baseline (caregiver only)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in post-stroke reintegration from baseline (patient only)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in caregiver burden from baseline (caregiver only)
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in self-efficacy from baseline (patient only)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antral cross-sectional area (CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of subjects indicating non-zero pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOB related survey responses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Developmental Coordination Disorder Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plasma concentration of zinc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration of Vitamin C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration of Folate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration of calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Experience of erotic and sexual risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood Biomarkers Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain MRI Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difficulty during catheterisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDAI remission (≤2.8) at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in centre of pressure (COP) from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weight distribution in quiet standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of pembrolizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Femoral external rotation on CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Femoral external rotation on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative femoral external rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute kidney injury ≥ stage 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dose Limiting Toxicity(ies)
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of prostate cancer and/or metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Acute Kidney Injury incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Acute Kidney Injury severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Functional Pelvic Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Impact Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Low Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of endometrial cancer and precancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: maintenance of virologic suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonate's weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonate's number of diaper exchange
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonate's total feeding amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Anxiety Scale on Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trait Anxiety Scale on Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Me and My Feelings Scale on Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ratio of treatment change of OAB symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic Response Rate (pRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient- and operator-centered outcomes assessed through VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental energy via Cognitive Demand Battery (CDB) Performance Index
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average change in knowledge survey score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Shared Decision Making Process Scores
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Cardiac output variability (ΔCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall pressure distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of individuals at high risk for gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: elastography values of the brachial plexus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal isometric voluntary contraction of knee extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Idiopathic hypersomnia severity scale (IHSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of satisfactory analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of ropivacaine per unit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cellular and molecular characteristics of remission in RA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time spent within the targeted normoxemia range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Problem behaviors in preschoolers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anti-tumor activity of TRX-221
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Non-inferiority of ICG SLNB compared to dual-tracer SLNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CRC screening knowledge and awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CRC screening intentions
Endpoint domain: Life impact
Endpoint subdomain: Behavioral intentions
Primary endpoint: Presence of psychoactive substances
Endpoint domain: Adverse events/effects
Primary endpoint: Revised Oswestry thoracic pain disability questionnaire for disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inclinometer measurement of Thoracic ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes